Loading
institutionsInstitution
Tohoku University Hospital
Sendai's university hospital and the clinical arm of the Tohoku Medical Megabank, with strengths in breast cancer, gastroenterology and imaging.
Also called: 東北大学病院
Overview
Tohoku University Hospital is the leading academic hospital of north-eastern Japan and a designated core hospital for cancer genome medicine. Tohoku University's Institute of Development, Aging and Cancer and the Tohoku Medical Megabank Organization, created after the 2011 earthquake, provide large genomic and cohort resources, and the hospital is known for breast cancer research (including steroid receptor pathology under Hironobu Sasano), gastrointestinal endoscopy and surgery, thoracic surgery and radiological sciences. Its investigators are active in JCOG, the Japan Breast Cancer Research Group and hepatology trials, and the Tohoku region operates one of Japan's newer proton facilities nearby.
Location
Sendai, JP
Type
hospital · Tohoku University
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#345 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Tohoku University Hospital, including child institutions. 161 works · 936 citations · 80% open access · 20% clinical trials · 1% reviews.
Oncology works per year
362022
342023
402024
262025
252026
Most works
- Eisaku Miyauchi17 works
- Kota Ouchi14 works
- Keigo Komine12 works
- Chikashi Ishioka11 works
- Toshihiro Misumi10 works
- Masanobu Takahashi9 works
- Takanori Teshima8 works
- Hidekazu Shirota8 works
- Nariyasu Mano8 works
- Makoto Nishio8 works
Most cited
- Breast cancer pathology and trials
- Tohoku Medical Megabank cohorts
- Gastroenterology
- Radiological sciences
Similar pages
- InstitutionShizuoka Cancer Center
Shares Whole-exome & whole-genome sequencing, Germline (hereditary) testing, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- PersonMitch Dowsett
Shares Estrogen receptor (ERα), Histopathology & immunohistochemistry, HR-positive / HER2-negative breast cancer.
- IdeaStore adult-onset cancer gene results from newborn genomes and disclose at 18
Shares Whole-exome & whole-genome sequencing, Germline (hereditary) testing.
- PersonChristina Curtis
Shares Whole-exome & whole-genome sequencing, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- CompanyOutcomes4Me
Shares Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Colorectal cancer, Non-small-cell lung cancer.
- IdeaOncology teams order germline tests; tele-genetic counsellors handle the results
Shares Germline (hereditary) testing, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- IdeaTest DPYD, UGT1A1 and TPMT/NUDT15 before the first dose, everywhere
Shares Germline (hereditary) testing, Gastric & gastro-oesophageal junction cancer, Colorectal cancer.
- CompanyHaystack Oncology
Shares Whole-exome & whole-genome sequencing, Colorectal cancer, Non-small-cell lung cancer.